Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice - PubMed (original) (raw)

Oral administration of probiotic bacteria (E. coli Nissle, E. coli O83, Lactobacillus casei) influences the severity of dextran sodium sulfate-induced colitis in BALB/c mice

A Kokesová et al. Folia Microbiol (Praha). 2006.

Abstract

Our study examined whether repeated preventive oral administration of live probiotic bacterial strains Escherichia coli O83:K24:H31 (Ec O83), Escherichia coli Nissle 1917 O6:K5:H1 (Ec Nis) and Lactobacillus casei DN 114001 (Lc) can protect mice against dextran sodium sulfate (DSS)-induced colitis. A significant decrease in average symptom score was observed in Ec O83-, Ec Nis- and Lc-pretreated group (p < 0.05). Significant differences in body mass loss between Lc pretreated mice with DSS-induced colitis were found when compared with nontreated mice (p < 0.05). PBS pretreated mice had a significantly shorter colon than Ec O83-, Ec Nis- and Lc-pretreated mice (p < 0.05). Administration of Lc significantly decreased the severity of DSS induced histological marks of inflammation (p < 0.05). A significant difference (p < 0.05) was also found in specific IgA level against given probiotic in enteral fluid between colitic mice and healthy mice pretreated with Ec 083 and Ec Nis.

PubMed Disclaimer

References

    1. Infect Immun. 2002 Apr;70(4):2057-64 - PubMed
    1. Gastroenterology. 2001 Feb;120(3):622-35 - PubMed
    1. Folia Microbiol (Praha). 2005;50(5):443-7 - PubMed
    1. Clin Exp Immunol. 1995 Dec;102(3):448-55 - PubMed
    1. Gastroenterology. 2001 Sep;121(3):580-91 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources